RxDoctor Payments Data

Brittany Seifert

Psychiatric/Mental Health · Springdale, ARNPI 1295194132

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,035, 4.3 times the $239 reported in 2021.

$3,590in general payments, 2019–2025

Across 194 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$743
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$693
  • Vanda Pharmaceuticals Inc.$407
  • Johnson & Johnson$338
  • Otsuka America Pharmaceutical, Inc.$335
  • Alkermes, Inc.$225
  • plus $848 from 8 others

What the payments were for

  • Food & beverage$3,590100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,590 in reported general payments places this provider in the 85th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$12,933
Medicare patients
21
Services billed
181

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole14$925
Vilazodone Hcl14$794
Bupropion XlBupropion Hcl28$579
Hydroxyzine Hcl19$480
Sertraline Hcl55$383
Duloxetine Hcl12$352
Lamotrigine33$284
Prazosin Hcl16$245
Buspirone Hcl24$237
Quetiapine Fumarate29$224
Fluoxetine Hcl73$204
Trazodone Hcl32$168
Alprazolam18$117
Clonazepam23$108
Escitalopram Oxalate13$68

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →